Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Medicine & Life Sciences

• Ticagrelor 100%
• Percutaneous Coronary Intervention 70%
• Coronary Artery Disease 58%
• Placebos 48%
• Randomized Controlled Trials 47%
• Aspirin 13%
• Hemorrhage 9%
• Myocardial Infarction 5%
• Stroke 5%
• Intracranial Hemorrhages 4%
• Coronary Artery Bypass 3%
• Documentation 3%
• Intention 3%
• Coronary Vessels 3%
• Pathologic Constriction 2%
• Diabetes Mellitus 2%
• Cause of Death 2%
• Population 2%
• Type 2 Diabetes Mellitus 2%
• Therapeutics 2%
• Health 1%
• Pharmaceutical Preparations 1%